Type a term, then click a field below.

Search | advanced search

keepers


Type a term, then click a field below.

Search | simple search





0 subtopics

 

Angiogenesis InhibitorsFollow by RSS 

You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.

keywords > Chemical Actions and Uses > Pharmacologic Actions > Physiological Effects of Drugs > Growth Substances > Angiogenesis Modulating Agents > Angiogenesis Inhibitors

Latest papers

Safety and efficacy of first-line bevacizumab with chemotherapy in Asian patients with advanced nonsquamous NSCLC: results from the phase IV MO19390 (SAiL) study.

Phase II trial of sunitinib maintenance therapy after platinum-based chemotherapy in patients with extensive-stage small cell lung cancer.

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with endostar for advanced non-small cell lung cancer.

The emerging role of vascular endothelial growth factor (VEGF) in vascular homeostasis: lessons from recent trials with anti-VEGF drugs.

Combinational therapy of interferon-α and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanoma.

Anti-angiogenic effects of betulinic acid administered in nanoemulsion formulation using chorioallantoic membrane assay.

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.

Ramucirumab (IMC-1121B): Monoclonal antibody inhibition of vascular endothelial growth factor receptor-2.

Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis.

Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer.

Targeted biotherapy in metastatic colorectal carcinoma: Current practice.

Targeted therapies for thymic malignancies.

Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors.

Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.

Signaling pathways governing tumor angiogenesis.

Anti-inflammatory approaches that target the chemokine network.

Calotropis procera root extracts block VEGF-induced angiogenesis: quantitative analysis.

Tumor angiogenesis: molecular pathways and therapeutic targets.

[Strategies of breast cancer treatment based on determination of biological subtype].

[Combined photodynamic therapy and intravitreal injection of triamcinolone acetonide in patients with wet form of AMD. Introductory report].

page 1 2 3 4 5 6 7 8 9 10 11 ...